REQUEST A DEMO
Total
USD $0.00
Search more companies

Burapha Dispensary Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Burapha Dispensary Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Burapha Dispensary Company Limited is a company based in Thailand, with its head office in Nonthaburi. It operates in the Pharmaceutical Preparation Manufacturing industry. Burapha Dispensary Company Limited was incorporated on May 14, 1985. There are currently 200 (estimated) people employed by Burapha Dispensary Company Limited. From the latest financial highlights, Burapha Dispensary Company Limited reported a net sales revenue drop of 10.86% in 2024. Its’ total assets recorded a negative growth of 1.34%. The enterprise’s net profit margin increased by 0.16% in 2024.

Headquarters
20 Soi Ngam Wong Wan 6 Yeak 3
Nonthaburi; Central Thailand; Postal Code: 11000

Contact Details: Purchase the Burapha Dispensary Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Burapha Dispensary Company Limited report to view the information.
Financial Auditors:
Purchase the Burapha Dispensary Company Limited report to view the information.
Incorporation Date:
May 14, 1985
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Burapha Dispensary Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-10.86%
Total Operating Revenue
-12.05%
Operating Profit
3.19%
EBITDA
3.19%
Net Profit/Loss for the Period
1362.42%
Total Assets
-1.34%
Total Equity
0.5%
Operating Profit Margin
0.81%
Net Profit Margin
0.16%
Return on Equity (ROE)
0.47%
Debt / Equity
-21.9%
Quick Ratio
0.01%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?